ken
Member
- Joined
- Oct 31, 2012
- Messages
- 288
Anyone signing up for the clinical trials?
"So what is this vaccine candidate, anyway? It’s being developed by the Gamaleya Research Institute, and it’s reported to be a mixture of two adenovirus vectors, Ad5 and Ad26. I’m still not sure what the idea behind giving both of those might be, but those two approaches are of course being used separately by other vaccine developers. The Gamaleya folks seem to like these mixed-vector vaccines – here’s a VSV/Ad5 Ebola candidate they were working on. Overall, the idea behind the vaccine doesn’t seem to be bizarre at all, though – just the development timelines."
"So what is this vaccine candidate, anyway? It’s being developed by the Gamaleya Research Institute, and it’s reported to be a mixture of two adenovirus vectors, Ad5 and Ad26. I’m still not sure what the idea behind giving both of those might be, but those two approaches are of course being used separately by other vaccine developers. The Gamaleya folks seem to like these mixed-vector vaccines – here’s a VSV/Ad5 Ebola candidate they were working on. Overall, the idea behind the vaccine doesn’t seem to be bizarre at all, though – just the development timelines."